Opposing Effects of Glutamine and Asparagine Govern Prion Formation by Intrinsically Disordered Proteins

Molecular Cell

Volumn 43, Issue 1, 2011, Pages 72-84

  Halfmann, Randal ^a,b   Alberti, Simon ^a   Krishnan, Rajaraman ^a   Lyle, Nicholas ^e   O'Donnell, Charles W ^a,c,d   King, Oliver D ^f   Berger, Bonnie ^b,c   Pappu, Rohit V ^e   Lindquist, Susan ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d USA   (United States)

^e WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^f BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ASPARAGINE; GLUTAMINE; PRION PROTEIN;

ARTICLE; BIOCHEMICAL COMPOSITION; BIOLOGY; CYTOLOGY; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRION; PROCESS MODEL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DEFECT; PROTEIN FOLDING;

AMINO ACID SEQUENCE; AMYLOID; ASPARAGINE; GLUTAMINE; MOLECULAR SEQUENCE DATA; PEPTIDE TERMINATION FACTORS; PRIONS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE ANALYSIS, PROTEIN;

BACTERIA (MICROORGANISMS);

EID: 79959882243     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2011.05.013     Document Type: Article

References (79)

1. Alberti S., Halfmann R., King O., Kapila A., Lindquist S. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 2009, 137:146-158.
2. Allen K.D., Chernova T.A., Tennant E.P., Wilkinson K.D., Chernoff Y.O. Effects of ubiquitin system alterations on the formation and loss of a yeast prion. J. Biol. Chem. 2007, 282:3004-3013.
3. Buchan J.R., Muhlrad D., Parker R. P bodies promote stress granule assembly in Saccharomyces cerevisiae. J. Cell Biol. 2008, 183:441-455.
4. Chernoff Y.O., Lindquist S.L., Ono B., Inge-Vechtomov S.G., Liebman S.W. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 1995, 268:880-884.
5. Chernoff Y.O., Newnam G.P., Kumar J., Allen K., Zink A.D. Evidence for a protein mutator in yeast: role of the Hsp70-related chaperone ssb in formation, stability, and toxicity of the [PSI] prion. Mol. Cell. Biol. 1999, 19:8103-8112.
6. Decker C.J., Teixeira D., Parker R. Edc3p and a glutamine/asparagine-rich domain of Lsm4p function in processing body assembly in Saccharomyces cerevisiae. J. Cell Biol. 2007, 179:437-449.
7. Derkatch I.L., Chernoff Y.O., Kushnirov V.V., Inge-Vechtomov S.G., Liebman S.W. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 1996, 144:1375-1386.
8. Derkatch I.L., Bradley M.E., Hong J.Y., Liebman S.W. Prions affect the appearance of other prions: the story of [PIN(+)]. Cell 2001, 106:171-182.
9. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997, 277:1990-1993.
10. Dong J., Castro C.E., Boyce M.C., Lang M.J., Lindquist S. Optical trapping with high forces reveals unexpected behaviors of prion fibrils. Nat. Struct. Mol. Biol. 2010, 17:1422-1430.
11. Dueholm M.S., Petersen S.V., Sønderkær M., Larsen P., Christiansen G., Hein K.L., Enghild J.J., Nielsen J.L., Nielsen K.L., Nielsen P.H., et al. Functional amyloid in Pseudomonas. Mol. Microbiol. 2010, 77:1009-1020.
12. Duennwald M.L., Jagadish S., Giorgini F., Muchowski P.J., Lindquist S. A network of protein interactions determines polyglutamine toxicity. Proc. Natl. Acad. Sci. USA 2006, 103:11051-11056.
13. Fernandez-Escamilla A.M., Rousseau F., Schymkowitz J., Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 2004, 22:1302-1306.
14. Finkelstein A.V. Rate of beta-structure formation in polypeptides. Proteins 1991, 9:23-27.
15. Fiumara F., Fioriti L., Kandel E.R., Hendrickson W.A. Essential role of coiled coils for aggregation and activity of Q/N-rich prions and PolyQ proteins. Cell 2010, 143:1121-1135.
16. Fuxreiter M., Tompa P., Simon I., Uversky V.N., Hansen J.C., Asturias F.J. Malleable machines take shape in eukaryotic transcriptional regulation. Nat. Chem. Biol. 2008, 4:728-737.
17. Glover J.R., Kowal A.S., Schirmer E.C., Patino M.M., Liu J.J., Lindquist S. Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell 1997, 89:811-819.
18. Grimminger V., Richter K., Imhof A., Buchner J., Walter S. The prion curing agent guanidinium chloride specifically inhibits ATP hydrolysis by Hsp104. J. Biol. Chem. 2004, 279:7378-7383.
19. Gsponer J., Futschik M.E., Teichmann S.A., Babu M.M. Tight regulation of unstructured proteins: from transcript synthesis to protein degradation. Science 2008, 322:1365-1368.
20. Halfmann R., Lindquist S. Epigenetics in the extreme: prions and the inheritance of environmentally acquired traits. Science 2010, 330:629-632.
21. Halfmann R., Alberti S., Lindquist S. Prions, protein homeostasis, and phenotypic diversity. Trends Cell Biol. 2010, 20:125-133.
22. Hammer N.D., Wang X., McGuffie B.A., Chapman M.R. Amyloids: friend or foe?. J. Alzheimers Dis. 2008, 13:407-419.
23. Harrison P.M., Gerstein M. A method to assess compositional bias in biological sequences and its application to prion-like glutamine/asparagine-rich domains in eukaryotic proteomes. Genome Biol. 2003, 4:R40.
24. He B., Wang K., Liu Y., Xue B., Uversky V.N., Dunker A.K. Predicting intrinsic disorder in proteins: an overview. Cell Res. 2009, 19:929-949.
25. Jenkins J., Pickersgill R. The architecture of parallel beta-helices and related folds. Prog. Biophys. Mol. Biol. 2001, 77:111-175.
26. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300:486-489.
27. Kawai-Noma S., Pack C.G., Kojidani T., Asakawa H., Hiraoka Y., Kinjo M., Haraguchi T., Taguchi H., Hirata A. In vivo evidence for the fibrillar structures of Sup35 prions in yeast cells. J. Cell Biol. 2010, 190:223-231.
28. Kodali R., Wetzel R. Polymorphism in the intermediates and products of amyloid assembly. Curr. Opin. Struct. Biol. 2007, 17:48-57.
29. Krishnan R., Lindquist S.L. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 2005, 435:765-772.
30. Krobitsch S., Lindquist S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc. Natl. Acad. Sci. USA 2000, 97:1589-1594.
31. Kryndushkin D.S., Alexandrov I.M., Ter-Avanesyan M.D., Kushnirov V.V. Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J. Biol. Chem. 2003, 278:49636-49643.
32. Lancaster A.K., Bardill J.P., True H.L., Masel J. The spontaneous appearance rate of the yeast prion [PSI+] and its implications for the evolution of the evolvability properties of the [PSI+] system. Genetics 2010, 184:393-400.
33. Larsen P., Nielsen J.L., Dueholm M.S., Wetzel R., Otzen D., Nielsen P.H. Amyloid adhesins are abundant in natural biofilms. Environ. Microbiol. 2007, 9:3077-3090.
34. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993, 2:404-410.
35. Lupas A., Van Dyke M., Stock J. Predicting coiled coils from protein sequences. Science 1991, 252:1162-1164.
36. McDonnell A.V., Jiang T., Keating A.E., Berger B. Paircoil2: improved prediction of coiled coils from sequence. Bioinformatics 2006, 22:356-358.
37. Meriin A.B., Zhang X., He X., Newnam G.P., Chernoff Y.O., Sherman M.Y. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J. Cell Biol. 2002, 157:997-1004.
38. Meriin A.B., Zhang X., Alexandrov I.M., Salnikova A.B., Ter-Avanesian M.D., Chernoff Y.O., Sherman M.Y. Endocytosis machinery is involved in aggregation of proteins with expanded polyglutamine domains. FASEB J. 2007, 21:1915-1925.
39. Michelitsch M.D., Weissman J.S. A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. Proc. Natl. Acad. Sci. USA 2000, 97:11910-11915.
40. Mukhopadhyay S., Krishnan R., Lemke E.A., Lindquist S., Deniz A.A. A natively unfolded yeast prion monomer adopts an ensemble of collapsed and rapidly fluctuating structures. Proc. Natl. Acad. Sci. USA 2007, 104:2649-2654.
41. Nelson R., Eisenberg D. Recent atomic models of amyloid fibril structure. Curr. Opin. Struct. Biol. 2006, 16:260-265.
42. Osherovich L.Z., Cox B.S., Tuite M.F., Weissman J.S. Dissection and design of yeast prions. PLoS Biol. 2004, 2:E86.
43. Pappu R.V., Wang X., Vitalis A., Crick S.L. A polymer physics perspective on driving forces and mechanisms for protein aggregation. Arch. Biochem. Biophys. 2008, 469:132-141.
44. Patel B.K., Gavin-Smyth J., Liebman S.W. The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion. Nat. Cell Biol. 2009, 11:344-349.
45. Perutz M.F., Windle A.H. Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats. Nature 2001, 412:143-144.
46. Perutz M.F., Pope B.J., Owen D., Wanker E.E., Scherzinger E. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid beta-peptide of amyloid plaques. Proc. Natl. Acad. Sci. USA 2002, 99:5596-5600.
47. Pierce M.M., Baxa U., Steven A.C., Bax A., Wickner R.B. Is the prion domain of soluble Ure2p unstructured?. Biochemistry 2005, 44:321-328.
48. Radivojac P., Iakoucheva L.M., Oldfield C.J., Obradovic Z., Uversky V.N., Dunker A.K. Intrinsic disorder and functional proteomics. Biophys. J. 2007, 92:1439-1456.
49. Romero P., Obradovic Z., Li X., Garner E.C., Brown C.J., Dunker A.K. Sequence complexity of disordered protein. Proteins 2001, 42:38-48.
50. Ross E.D., Edskes H.K., Terry M.J., Wickner R.B. Primary sequence independence for prion formation. Proc. Natl. Acad. Sci. USA 2005, 102:12825-12830.
51. Ross E.D., Minton A., Wickner R.B. Prion domains: sequences, structures and interactions. Nat. Cell Biol. 2005, 7:1039-1044.
52. Salazar A.M., Silverman E.J., Menon K.P., Zinn K. Regulation of synaptic Pumilio function by an aggregation-prone domain. J. Neurosci. 2010, 30:515-522.
53. Serio T.R., Cashikar A.G., Kowal A.S., Sawicki G.J., Moslehi J.J., Serpell L., Arnsdorf M.F., Lindquist S.L. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 2000, 289:1317-1321.
54. Shewmaker F., McGlinchey R.P., Thurber K.R., McPhie P., Dyda F., Tycko R., Wickner R.B. The functional curli amyloid is not based on in-register parallel beta-sheet structure. J. Biol. Chem. 2009, 284:25065-25076.
55. Shorter J., Lindquist S. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 2004, 304:1793-1797.
56. Si K., Lindquist S., Kandel E.R. A neuronal isoform of the aplysia CPEB has prion-like properties. Cell 2003, 115:879-891.
57. Singh G.P., Chandra B.R., Bhattacharya A., Akhouri R.R., Singh S.K., Sharma A. Hyper-expansion of asparagines correlates with an abundance of proteins with prion-like domains in Plasmodium falciparum. Mol. Biochem. Parasitol. 2004, 137:307-319.
58. Takahashi T., Kikuchi S., Katada S., Nagai Y., Nishizawa M., Onodera O. Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. Hum. Mol. Genet. 2008, 17:345-356.
59. Tartaglia G.G., Vendruscolo M. The Zyggregator method for predicting protein aggregation propensities. Chem. Soc. Rev. 2008, 37:1395-1401.
60. Tessier P.M., Lindquist S. Unraveling infectious structures, strain variants and species barriers for the yeast prion [PSI+]. Nat. Struct. Mol. Biol. 2009, 16:598-605.
61. Titz B., Thomas S., Rajagopala S.V., Chiba T., Ito T., Uetz P. Transcriptional activators in yeast. Nucleic Acids Res. 2006, 34:955-967.
62. Toombs J.A., McCarty B.R., Ross E.D. Compositional determinants of prion formation in yeast. Mol. Cell. Biol. 2010, 30:319-332.
63. Treusch S., Cyr D.M., Lindquist S. Amyloid deposits: protection against toxic protein species?. Cell Cycle 2009, 8:1668-1674.
64. Truant R., Atwal R.S., Desmond C., Munsie L., Tran T. Huntington's disease: revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases. FEBS J. 2008, 275:4252-4262.
65. True H.L., Lindquist S.L. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 2000, 407:477-483.
66. Turoverov K.K., Kuznetsova I.M., Uversky V.N. The protein kingdom extended: ordered and intrinsically disordered proteins, their folding, supramolecular complex formation, and aggregation. Prog. Biophys. Mol. Biol. 2010, 102:73-84.
67. Tyedmers J., Treusch S., Dong J., McCaffery J.M., Bevis B., Lindquist S. Prion induction involves an ancient system for the sequestration of aggregated proteins and heritable changes in prion fragmentation. Proc. Natl. Acad. Sci. USA 2010, 107:8633-8638.
68. Uversky V.N. Amyloidogenesis of natively unfolded proteins. Curr. Alzheimer Res. 2008, 5:260-287.
69. Vavouri T., Semple J.I., Garcia-Verdugo R., Lehner B. Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity. Cell 2009, 138:198-208.
70. Vitalis A., Lyle N., Pappu R.V. Thermodynamics of beta-sheet formation in polyglutamine. Biophys. J. 2009, 97:303-311.
71. Vitalis A., Wang X., Pappu R.V. Quantitative characterization of intrinsic disorder in polyglutamine: insights from analysis based on polymer theories. Biophys. J. 2007, 93:1923-1937.
72. Vitalis A., Wang X., Pappu R.V. Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization. J. Mol. Biol. 2008, 384:279-297.
73. Walters R.H., Murphy R.M. Examining polyglutamine peptide length: a connection between collapsed conformations and increased aggregation. J. Mol. Biol. 2009, 393:978-992.
74. Wang X., Vitalis A., Wyczalkowski M.A., Pappu R.V. Characterizing the conformational ensemble of monomeric polyglutamine. Proteins 2006, 63:297-311.
75. Wasmer C., Lange A., Van Melckebeke H., Siemer A.B., Riek R., Meier B.H. Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core. Science 2008, 319:1523-1526.
76. Weathers E.A., Paulaitis M.E., Woolf T.B., Hoh J.H. Reduced amino acid alphabet is sufficient to accurately recognize intrinsically disordered protein. FEBS Lett. 2004, 576:348-352.
77. Williamson T.E., Vitalis A., Crick S.L., Pappu R.V. Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin. J. Mol. Biol. 2010, 396:1295-1309.
78. Xiao H., Jeang K.T. Glutamine-rich domains activate transcription in yeast Saccharomyces cerevisiae. J. Biol. Chem. 1998, 273:22873-22876.
79. Zhang J., Muthukumar M. Simulations of nucleation and elongation of amyloid fibrils. J. Chem. Phys. 2009, 130:035102.